Clinical Trial

High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)

Study acronym: TASS-2
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 1, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT02448485
Lead Sponsor Medical University Innsbruck
Conditions Aortic Stenosis, Heart Failure, Syncope, Angina Pectoris
Enrollment 10,000 participants
Start Date 2015-06
Primary Completion 2025-10 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2024-08-01